___

Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885-90.

Eckart RE, Shry EA, Burke AP, et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011;58:1254-61.

Remes J, Helin M, Vaino P, et al. Clinical outcome and left ventricular function 23 years after acute coxsackie virus myopericarditis. Eur Heart J. 1990; 11: 182-8.

Tschöpe C, Cooper LT, Torre-Amione G, et al. Management of Myocarditis- Related Cardiomyopathy in Adults. Circ Res. 2019;124:1568-83.

Panchal HB, Daggubati R, Zhao D, et al. Polymer-Free Drug-Coated Coronary Stents in Patients with Stable Coronary Artery Disease at High Bleeding Risk. Curr Cardiol Rep. 2017;19:12.

Bracamonte-Baran W and Čiháková D, Cardiac Autoimmunity: Myocarditis. Adv Exp Med Biol. 2017;1003:187-221.

Ancuta P, Wang J, and Gabuzda D, CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006; 80: 1156-64.

Cockerill GW, Rye KA, Gamble JR, et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15:1987-94.

Cetin EH, Cetin MS, Canpolat U, et al. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med.2015;9:967-77.

Ekizler FA, Cay S, Açar B, et al. Monocyte to high-density lipoprotein cholesterol ratio predicts adverse cardiac events in patients with hypertrophic cardiomyopathy. Biomark Med. 2019;13:1175-86.

Fabre A and Sheppard MN, Sudden adult death syndrome and other nonischaemic causes of sudden cardiac death. Heart. 2006;92:316-20.

Shao L, Ma A, Figtree G, et al. Combination therapy with coenzyme q10 and trimetazidine in patients with acute viral myocarditis. J Cardiovasc Pharmacol. 2016;68:150-4.

Younis A, Matetzky S, Mulla W, et al. Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis. Am J Med. 2020;133:492-99.

Kindermann I, Kindermann M, Kandolf R, et al. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008;118:639-48.

Ammirati E, Veronese G, Brambatti M, et al. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2019;74:299-311.

Ammirati E, Cipriani M, Moro C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter lombardy registry. Circulation. 2018;138:1088-99.

Kato S, Morimoto S, Hiramitsu S, et al., Risk factors for patients developing a fulminant course with acute myocarditis. Circ J. 2004;68:734-9.

Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis. Heart. 2012;98:835-40.

Buggey J and Elamm CA, Myocarditis and cardiomyopathy. Curr Opin Cardiol. 2018;33:341-46.

Imanaka-Yoshida K, Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy. Pathol Int. 2020;70:1-11.

Berg J, Kottwitz J, Baltensperger N, et al. Cardiac magnetic resonance imaging in myocarditis reveals persistent disease activity despite normalization of cardiac enzymes and inflammatory parameters at 3-month follow-up. Circ Heart Fail. 2017;10.

Tada Y and Suzuki J, Oxidative stress and myocarditis. Curr Pharm Des. 2016;22:450-71.

Mann DL, Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91:988-98.

Ekizler FA and Cay S, A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte countto- HDL cholesterol ratio. BMC Cardiovasc Disord. 2019;19:114.

Frantz S, Bauersachs J, and Ertl G, Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res. 2009;81:474-81.

Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol. 2008;130:147-58.

Apostolakis S, Lip GY, Shantsila E. Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res. 2010;85:649-60.

Wrigley BJ, Shantsila E, Tapp LD, et al. CD14++CD16+ monocytes in patients with acute ischaemic heart failure. Eur J Clin Invest. 2013;43:121- 30.

Murphy AJ and Woollard KJ, High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37:710-8.

Yvan-Charvet L, Pagler T, Gautier EL, et al., ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010;328:1689-93.

Murphy AJ, Chin-Dusting JP, Sviridov D, et al. The anti inflammatory effects of high density lipoproteins. Curr Med Chem. 2009;16:667-75.

Kundi H, Gok M, Kiziltunc E, et al., Relation between monocyte to highdensity lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia. Am J Cardiol. 2015;116:1685-9.

Canpolat U, Çetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016;22:476-82.

Demir V, Samet Y, and Akboga MK. Association of lymphocyte-monocyte ratio and monocyte-to-high-density lipoprotein ratio with the presence and severity of rheumatic mitral valve stenosis. Biomark Med. 2017;11:657-63.

Yilmaz S, Akboga MK, Sen F, et al. Usefulness of the monocyte-to-highdensity lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10:959-66.